Award
NIH Reporter #1R01CA303943-01A1
Randomized Trial of a Novel Intervention to Increase Endocrine Therapy Adherence among Depressed Breast Cancer Survivors
Recipient
University of Colorado, Boulder, CO, USA
Award Amount
$653,413.00
Ceiling
$653,413.00
Awarded
September 17, 2026
Identifier
1R01CA303943-01A1
A research project funded by the National Cancer Institute to test a novel intervention (REACH+) aimed at improving medication adherence among depressed breast cancer survivors through behavioral strategies and telehealth support.
Description
This project evaluates an innovative, community-embedded intervention (REACH+) focused on breast cancer survivors at high risk of poor adherence to oral endocrine therapy. The intervention combines personal values-based strategies with behavioral treatments for depression, delivered via online sessions supported by telehealth coaching and personalized decision trees to manage side effects. The study aims to assess the short-term and long-term effects of REACH+ on medication adherence, persistence, side effects, depression, and quality of life.